VALUE-BASED DRUG REIMBURSEMENT: INTRODUCTION TO THE MAIN FEATURES OF THE GERMAN PHARMACEUTICAL POLICY
Sep 29, 2015
Presentado por:
Dr. Wolfgang Greiner
In this CRITERIA webinar, our guest, Dr. Wolfgang Greiner, delves into drug price regulation based on additional therapeutic value and the role of cost-benefit evaluations, based on the experience of Germany, after the reforms implemented in 2011.
Archivos adicionales
Artículos recomendados